Showing results (2681-2690 of 11,115) with videos related to
Sort By:
Pageof 1,112
Journal of Neurology|June 1, 2026
Association of probiotic medication use with incident Parkinson disease and alzheimer disease: a nationwide nested case-control studyYasutaka Ihara, Noriyuki Miyaue, Miho Ihara, et al.Journal of Neurology|June 2, 2026
What if it is the eyes? The effect of eye movement disorders on cognitive testing in MSS N Hof, E Keytsman, T A N Fuchs, et al.Journal of Neurology|January 13, 2005
European validation of a standardized clinical description of multiple sclerosisMaria Pia Amato, Jerome Grimaud, Iuliana Achiti, et al.Journal of Neurology|August 18, 1977
The fatty acid composition of sphingomyelin from adult human cerebral white matter and changes in childhood, senium and unspecific brain damageR Heipertz, H Pilz, W ScholzJournal of Neurology|June 3, 2026
Progressive disability but survival advantage in anti-Hu/ANNA1 paraneoplastic neurological syndromesKimberly A DiMauro, Nicolas R Thompson, Brittany Lapin, et al.Journal of Neurology|June 5, 2026
Emerging insight in genetics and therapies in young-onset Parkinson's disease (YOPD): a comprehensive reviewGrace Hey, Hikaru Kamo, Gilberto Perez Rodriguez Garcia, et al.Journal of Neurology|June 3, 2026
Ultra-low-field MRI for bedside imaging of severe multiple sclerosisNiels Bergsland, Alex Burnham, Michael G Dwyer, et al.Journal of Neurology|November 28, 2019
The impact of MEG results on surgical outcomes in patients with drug-resistant epilepsy associated with focal encephalomalacia: a single-center experienceXinghui He, Jian Zhou, Pengfei Teng, et al.Journal of Neurology|April 8, 2023
Migraine: from pathophysiology to treatmentFrancesca Puledda, Elisa Martins Silva, Kanokrat Suwanlaong, et al.Journal of Neurology|September 19, 2017
Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizuresVicente Villanueva, Martin Holtkamp, Norman Delanty, et al.Pageof 1,112